- After years of strategic adjustments, China's first publicly listed hair transplant company, YONGHE Medical, has achieved a turnaround in financial performance.
- In 2025, the group reported total revenue of 1.808 billion RMB, a slight increase of 0.2% year-on-year, with profit rebounding to 74 million RMB from a previous loss.
- The company's focus has shifted from expanding store numbers to enhancing profitability at established outlets, resulting in a significant rise in gross margin and a reduction in marketing costs.
